comparemela.com

Latest Breaking News On - Antibe therapeutics - Page 7 : comparemela.com

Impel Pharmaceuticals (NASDAQ:IMPL) vs Antibe Therapeutics (OTCMKTS:ATBPF) Head-To-Head Contrast

Impel Pharmaceuticals (NASDAQ:IMPL – Get Free Report) and Antibe Therapeutics (OTCMKTS:ATBPF – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations and institutional ownership. Valuation and Earnings This table compares Impel […]

Brookline Capital Management Equities Analysts Lower Earnings Estimates for Antibe Therapeutics Inc (OTCMKTS:ATBPF)

Brookline Capital Management Equities Analysts Lower Earnings Estimates for Antibe Therapeutics Inc (OTCMKTS:ATBPF)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Antibe Therapeutics (OTCMKTS:ATBPF) Issues Earnings Results

Antibe Therapeutics (OTCMKTS:ATBPF – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.02, MarketWatch Earnings reports. Antibe Therapeutics Trading Down 17.2 % Shares of OTCMKTS ATBPF opened at $0.55 on Wednesday. Antibe Therapeutics has a twelve […]

Antibe Therapeutics (OTCMKTS:ATBPF) Posts Earnings Results, Beats Estimates By $0 02 EPS

Antibe Therapeutics (OTCMKTS:ATBPF) Posts Earnings Results, Beats Estimates By $0 02 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Buy ATE stock for a double, Echelon says

Following the company’s Q2, 2024 interim results, Echelon analyst Stefan Quenneville still thinks there is money to be made on Antibe Therapeutics

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.